Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Firstly, the authors suggest (in table II) that a majority of women, whether entering the trial or not, preferred screening during pregnancy. This is not borne out by the results they present since, although small numbers are involved, 60.5% of the non-participants preferred screening before pregnancy, compared with 46% of the participants. A previous survey of pregnant women found that 98% preferred screening before pregnancy and 69% would accept carrier screening during pregnancy.2 There is actually substantial interest in prepregnancy screening. This is signficant because the acceptability of screening to the general population is likely to alter with the improving clinical picture for cystic fibrosis3 as well as gene therapy.
Secondly,
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?